Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022Hannah G. Rosenblum, Evelyn Twentyman, Oliver Brooks et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 163
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023Joanna J. Regan, Megan Wallace, Danielle Moulia et al.|MMWR Morbidity and Mortality Weekly Report|2023Cited by 142
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021Kathleen Dooling, Sara E. Oliver, Julia W. Gargano et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 41
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023Danielle Moulia, Evelyn Twentyman, Megan Wallace et al.|MMWR Morbidity and Mortality Weekly Report|2023Cited by 40
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022Evelyn Twentyman, Sara E. Oliver, Megan J. Wallace et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 31